I-High Purity Pharmaceutical Grade 877399-52-5 Crizotinib for Anti-cancer Treatment
Umkhiqizoigama | I-Crizotinib |
Omqondofana | PF-02341066;3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl) ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine;PF 2341066 |
Inombolo ye-CAS. | 877399-52-5 |
Ukubukeka | Impushana yekristalu emhlophe ukuya kokumhlophe |
I-Molecular Formula | C21H22Cl2FN5O |
Isisindo samangqamuzana | 450.34 |
Ukusetshenziswa | Ibanga Lezemithi noma inhloso yocwaningo |
Ukupakisha | Njengesicelo sakho |
Isitoreji | Londoloza ezitsheni eziqinile, ezimelana nokukhanya endaweni epholile |
I-CrizotinibCas: 877399-52-5 | ||
Izinto | Imininingwane | Imiphumela |
Ukubukeka | Impushana yekristalu emhlophe ukuya kokumhlophe | I-crystalline powder emhlophe |
Ukuhlonza | H-NMR, MS | Iyahambisana |
Izincibilikisi Ezisele | isopropanol≤0.5% I-EtOAc≤0.5% THF≤0.072% n-Heptane≤0.5% I-Toluene≤0.5% | 0.3% ND ND ND ND ND |
Izinsimbi Ezisindayo | ≤10ppm | Iyahambisana |
Okuqukethwe kwamanzi | £0.5% | 0.3% |
Izinsalela ekushiseni | £0.5% | 0.05% |
I-Enantiomer | £0.1% | <LOQ |
Ukungcola Okuhlobene kwe-HPLC | Ukungcola okukodwa≤0.1% Ukungcola okuphelele ≤1.0% | 0.05% 0.12% |
Ubumsulwa (HPLC) | ³99.0% | 99.88% |
Ulwazi Lwenkampani
√ Isipiliyoni esigcwele se-Management layer kubalandeli befektri nabanekhono; √ Ikhwalithi ihlale iwukucatshangelwa kwethu okuphezulu, uhlelo oluqinile lwe-QC; √ Ithimba leminyaka engu-11 elinesipiliyoni sokuthumela ngaphandle; √ Ilebhu ye-R&D ezimele; √ Izinkundla zokucobelelana ngolwazi ezimbili ze-GMP zesikhathi eside ezisayiniwe; √ Izinsiza ezicebile zamafekthri amaningi angasebenzi wephrojekthi eyenziwe ngokwezifiso; √ Ithimba elisebenzayo elisebenza kahle elinendlela engaguquki.Bhala umyalezo wakho lapha futhi usithumelele wona